Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing didanosine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine adverse reaction |
Causative agent (attribute) |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Allergy to didanosine |
Causative agent (attribute) |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 250 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 200 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Product containing precisely didanosine 125 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 100mg powder for oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 167mg/pkg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 250mg/pkg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 2g/bot powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 4g/bot powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Product containing precisely didanosine 125 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Product containing precisely didanosine 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Didanosine 400mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
|
Allergy to didanosine |
Causative agent (attribute) |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Allergy to didanosine |
Causative agent (attribute) |
False |
Didanosine (substance) |
Inferred relationship |
Some |
2 |
Didanosine 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 150 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 125 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 125 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 200 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 250 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 250 mg gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 250 mg gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 200 mg gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 200 mg gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 125 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 125 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing didanosine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 150 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 200 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 250 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 125 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing only didanosine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Didanosine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Didanosine (substance) |
Inferred relationship |
Some |
1 |